Vector Science and Therapeutics Corp. (TSXV:PAIN)
Canada · Delayed Price · Currency is CAD 1.660
-0.030 (-1.78%)
At close: Jun 1, 2026
Vector Science and Therapeutics Company Description
Vector Science and Therapeutics Corp. develops and sells novel biomechanical devices and active localized drug-delivery platforms.
The company offers products and services based on its Smart, Steered, and Sustained framework for site-directed interventions in musculoskeletal tissue regeneration.
The company has a development and manufacturing agreement with MPP Group LLC to develop and manufacture pharmaceutical-grade peptides and drug delivery devices.
The company is based in Mequon, Wisconsin.
Vector Science and Therapeutics Corp.
| Country | Canada |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | William Jackson |
Contact Details
Address: 12250 Corporate Parkway Mequon, Wisconsin 53092 United States | |
| Phone | (833) 832-8724 |
| Website | vectorscience.co |
Stock Details
| Ticker Symbol | PAIN |
| Exchange | TSX Venture Exchange |
| Fiscal Year | September - August |
| Reporting Currency | USD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| William Jackson | Chief Executive Officer, President and Director |
| Barry Hix | Co-Founder, Chief Commercial Officer and Director |
| Stephen Gledhill | Chief Financial Officer and Corporate Secretary |
| Thomas Bachinski | Chief Technology Officer |
| Dr. W. Bradley Worthington | Chief Medical Officer |